Yusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, Ryo Shimizu, Tadashi Kosaka, Koichi Sakaguchi, Naoya Dobuchi, Kohshi Nishiguchi, Keisuke Shikata. Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy. Biological & pharmaceutical bulletin. 2023. 46. 7. 964-968
Yusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, Tadashi Kosaka, Koichi Sakaguchi, Naoya Dobuchi, Kohshi Nishiguchi, Keisuke Shikata. Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen. Cancer Chemotherapy and Pharmacology. 2023. 91. 1. 25-31
Takuya Yoshida, Masayuki Tsujimoto, Sachiyo Kawakami, Haruno Fujioka, Yuko Irie, Saki Nakatani, Ayako Iso, Ayaka Sugiyama, Mizuho Miyake, Kazumi Hirato, et al. Research on the relationship between serum indoxyl sulfate concentration and iron dynamics index in patients with end-stage kidney disease: a cross-sectional study. Renal Replacement Therapy. 2022. 8. 1
Akio Ogawa, Daiki Hira, Masayuki Tsujimoto, Kohshi Nishiguchi, Masanori Endo, Toshiaki Ono, Tsuguru Hatta, Tomohiro Terada, Shin-ya Morita. Optimal Sampling Strategy and Threshold of Serum Vancomycin Concentration in Elderly Japanese Patients Undergoing High-Flux Hemodialysis. Therapeutic Drug Monitoring. 2022. 44. 3. 396-403
Yurie Katsube, Masayuki Tsujimoto, Hiroyoshi Koide, Daiki Hira, Yoshito Ikeda, Tetsuya Minegaki, Shin-ya Morita, Tomohiro Terada, Kohshi Nishiguchi. In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver. Drug Metabolism and Disposition. 2021. 49. 4. 289-297
